SkinVive

What is SkinVive?
SkinVive is the first and only FDA-approved injectable microdroplet treatment designed to boost skin hydration, smoothness, and radiance from within. Unlike traditional fillers, SkinVive doesn’t change your facial shape—it delivers hyaluronic acid directly into the skin, improving texture, glow, and softness for a refreshed, dewy complexion.
What are the targeted areas?
SkinVive is specially designed for:
- Cheeks – restore hydration and plumpness
- Fine lines – soften and smooth surface texture
- Overall glow – improve luminosity and skin quality
What is the treatment timeline?
Your SkinVive session takes about 30 minutes in the office. You may notice improved hydration and glow within 2–4 weeks as the hyaluronic acid integrates into the skin.
Skin looks its smoothest and most radiant around 1–2 months post-treatment, with continued hydration benefits. Results typically last up to 6 months. Most patients love refreshing their results twice a year, though timing can be personalized to your skin goals.
Appointment Duration: 30 Minutes
Timeline for Results: 4-6 weeks
Frequency of Visits: 2 visits per year
Cost: $725 per treatment

Frequently asked questions
How does SkinVive work?
SkinVive uses microdroplets of hyaluronic acid injected just beneath the skin’s surface. This hydrates the skin and improves smoothness for a radiant glow.
When will I see results?
Many patients notice improved skin hydration and glow within a few weeks, with continued improvements over the following months.
Is there any downtime?
Downtime is minimal. You may experience slight redness, swelling, or tenderness at the injection sites, which typically resolve in a few days.
Who is a good candidate for SkinVive?
SkinVive is ideal for patients seeking improved skin quality, hydration, and glow without adding volume or altering facial shape.
Can SkinVive be combined with other treatments?
Yes! SkinVive works beautifully alongside fillers, neuromodulators, and treatments like lasers or facials to enhance overall results.